Webinar on Ataxia-Telangiectasia Unmet Need Hosted by Quince Therapeutics Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company focused on advancing treatments for rare diseases, has announced that it will…
Nephritis in Active Lupus: Gazyva’s Superiority Proven in NEJM Dat Genentech, a member of the Roche Group, announced that a detailed analysis of its Phase III REGENCY trial of Gazyva®…
Culina Health Earns Spot on 2025 New York Digital Health 100 List, Recognized for Innovation in Nutrition Care Culina Health, a pioneering telehealth platform dedicated to transforming access to clinical…
Blood Sensor Inspira Technologies Advances AI-Powered Blood Sensor, Eyes Clinical Milestones Future Markets Research has released an update highlighting recent developments from Inspira Technologies a company at the forefront of…
mPulse Concludes 2024 on a High Note and Launches AI Center of Excellence to Drive Innovation in Healthcare mPulse®, a leader in Health Experience and Insights (HXI) technology, has announced…
Hinge Health Study Demonstrates Significant Reduction in Chronic Pelvic Pain and Depression Symptoms Chronic Pelvic Pain Hinge Health has announced the publication of a groundbreaking study in BMC Women’s Health…
Edifecs Unveils Healthcare Interoperability Cloud: A Strategic Leap Toward Seamless Data Exchange Edifecs a global leader in health information technology solutions, has announced the launch of its Healthcare Interoperability Cloud,…
Pediatric Genetic Fore Genomics Partners with Inocras to Revolutionize Pediatric Genetic Health Screening and Newborn Sequencing Pediatric Genetic Fore Genomics, a leading provider of pediatric genetic health screening, has announced…
Clinical Innovation UNC Health Expands Use of Abridge AI Technology to Enhance Patient and Clinician Experience Clinical Innovation UNC Health, one of the largest and most comprehensive healthcare systems in…
Understanding Cell and Gene Therapy Trials for Pediatric Rare Diseases: Join the Upcoming Xtalks Webinar Cell and gene therapy (CGT) has emerged as a promising treatment for rare diseases, particularly…
TriLink BioTechnologies Partners with Avantor to Expand Nucleic Acid Solutions in EMEA Region TriLink BioTechnologies® (TriLink), a global leader in providing life science reagents and services, has announced a strategic…
Inhalon Biopharma Advances Breakthrough Inhaled Antibody Treatment for RSV, Targets 2026 Human Trials Inhalon Biopharma, Inc., a clinical-stage company pioneering innovative treatments for acute respiratory infections (ARI), has announced a…